Literature DB >> 22155105

B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.

Vinita Singh-Gupta1, Sanjeev Banerjee, Christopher K Yunker, Joseph T Rakowski, Michael C Joiner, Andre A Konski, Fazlul H Sarkar, Gilda G Hillman.   

Abstract

Increased consumption of cruciferous vegetables is associated with decreased risk in prostate cancer (PCa). The active compound in cruciferous vegetables appears to be the self dimerized product [3,3'-diindolylmethane (DIM)] of indole-3-carbinol (I3C). Nutritional grade B-DIM (absorption-enhanced) has proven safe in a Phase I trial in PCa. We investigated the anti-cancer activity of B-DIM as a new biological approach to improve the effects of radiotherapy for hormone refractory prostate cancer cells, which were either positive or negative for androgen receptor (AR) expression. B-DIM inhibited cell growth in a dose-dependent manner in both PC-3 (AR-) and C4-2B (AR+) cell lines. B-DIM was effective at increasing radiation-induced cell killing in both cell lines, independently of AR expression. B-DIM inhibited NF-κB and HIF-1α DNA activities and blocked radiation-induced activation of these transcription factors in both PC-3 and C4-2B cells. In C4-2B (AR+) cells, AR expression and nuclear localization were significantly increased by radiation. However, B-DIM abrogated the radiation-induced AR increased expression and trafficking to the nucleus, which was consistent with decreased PSA secretion. In vivo, treatment of PC-3 prostate tumors in nude mice with B-DIM and radiation resulted in significant primary tumor growth inhibition and control of metastasis to para-aortic lymph nodes. These studies demonstrate that B-DIM augments radiation-induced cell killing and tumor growth inhibition. B-DIM impairs critical survival signaling pathways activated by radiation, leading to enhanced cell killing. These novel observations suggest that B-DIM could be used as a safe compound to enhance the efficacy of radiotherapy for castrate-resistant PCa.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155105      PMCID: PMC3288414          DOI: 10.1016/j.canlet.2011.12.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

1.  A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer.

Authors:  Elisabeth I Heath; Lance K Heilbrun; Jing Li; Ulka Vaishampayan; Felicity Harper; Pam Pemberton; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2010-07-23       Impact factor: 4.060

Review 2.  Using chemopreventive agents to enhance the efficacy of cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

3.  Radiation dose and late failures in prostate cancer.

Authors:  Peter B Morgan; Alexandra L Hanlon; Eric M Horwitz; Mark K Buyyounouski; Robert G Uzzo; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

Review 4.  Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Authors:  Sanjeev Banerjee; Dejuan Kong; Zhiwei Wang; Bin Bao; Gilda G Hillman; Fazlul H Sarkar
Journal:  Mutat Res       Date:  2011-06-15       Impact factor: 2.433

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 6.  Androgen receptor in prostate cancer.

Authors:  Cynthia A Heinlein; Chawnshang Chang
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

7.  Indole-3-carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells.

Authors:  M Nachshon-Kedmi; S Yannai; A Haj; F A Fares
Journal:  Food Chem Toxicol       Date:  2003-06       Impact factor: 6.023

8.  Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

Authors:  Gregory P Swanson; Michael A Hussey; Catherine M Tangen; Joseph Chin; Edward Messing; Edith Canby-Hagino; Jeffrey D Forman; Ian M Thompson; E David Crawford
Journal:  J Clin Oncol       Date:  2007-06-01       Impact factor: 44.544

9.  Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.

Authors:  Thirupandiyur S Udayakumar; Paul Hachem; Mansoor M Ahmed; Sudhir Agrawal; Alan Pollack
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

10.  Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study.

Authors:  J R Hebert; T G Hurley; B C Olendzki; J Teas; Y Ma; J S Hampl
Journal:  J Natl Cancer Inst       Date:  1998-11-04       Impact factor: 13.506

View more
  7 in total

1.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

2.  Microwave-assisted, one-pot reaction of 7-azaindoles and aldehydes: a facile route to novel di-7-azaindolylmethanes.

Authors:  Md Imam Uddin; Jason R Buck; Michael L Schulte; Dewei Tang; Samir A Saleh; Yiu-Yin Cheung; Joel Harp; H Charles Manning
Journal:  Tetrahedron Lett       Date:  2014-01-01       Impact factor: 2.415

3.  Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy.

Authors:  Irfana Muqbil; Ginny W Bao; Rkya El-Kharraj; Minjel Shah; Ramzi M Mohammad; Fazlul H Sarkar; Asfar S Azmi
Journal:  J Stem Cell Res Ther       Date:  2012-12-16

Review 4.  Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?

Authors:  Yiwei Li; Dejuan Kong; Aamir Ahmad; Bin Bao; Fazlul H Sarkar
Journal:  Antioxid Redox Signal       Date:  2013-03-14       Impact factor: 8.401

5.  Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model.

Authors:  Hossam Draz; Alexander A Goldberg; Emma S Tomlinson Guns; Ladan Fazli; Stephen Safe; J Thomas Sanderson
Journal:  Invest New Drugs       Date:  2018-04-02       Impact factor: 3.850

Review 6.  The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2012-05-10

7.  Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3'-diindolylmethane in an enzalutamide-resistant prostate cancer cell line.

Authors:  Chih-Wei Tsao; Jia-Sin Li; Ya-Wen Lin; Sheng-Tang Wu; Tai-Lung Cha; Chin-Yu Liu
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.